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Optimization of permanent seed implant brachytherapy plans for treatment of
prostate cancer should be based on biological effective dose (BED) distributions,
since dose does not accurately represent biological effects between different types
of sources. Currently, biological optimization for these plans is not feasible due to
the amount of time necessary to calculate the BED distribution. This study provides
a fast calculation method, based on the total dose, to calculate the BED distribution. Distributions of various numbers of hybrid seeds were used to calculate total
dose distributions, as well as BED distributions. Hybrid seeds are a mixture of
different isotopes (in this study 125I and 103Pd). Three ratios of hybrid seeds were
investigated: 25/75, 50/50, and 75/25. The total dose and BED value from each
voxel were coupled together to produce graphs of total dose vs. BED. Equations
were then derived from these graphs. The study investigated four types of tissue:
bladder, rectum, prostate, and other normal tissue. Equations were derived from the
total dose – BED correspondence. Accuracy of conversion from total dose to BED
was within 2 Gy; however, accuracy of conversion was found to be better for high
total dose regions as compared to lower dose regions. The method introduced in this
paper allows one to perform fast conversion of total dose to BED for brachytherapy
using hybrid seeds, which makes the BED-based plan optimization practical. The
method defined here can be extended to other ratios, as well as other tissues that
are affected by permanent seed implant brachytherapy (i.e., breast).
PACS number: 87.55.de
Key words: hybrid seeds, brachytherapy, optimization, BED
I.

Introduction

The linear-quadratic model is currently the most used model that quantitatively describes the
survivability of a cell line for a given amount of radiation. Deriving from the linear-quadratic
model, the biological effective dose (BED) describes the biological effects of radiation.(1,2)
Since BED provides a way of including radiobiological parameters, quantitative treatment
expectations can be obtained.(3) It has been suggested that BED be used as a guide in clinical
decision-making.(3-6) This requires the calculation of BED from dose. Several papers have addressed the conversion of dose to BED for fractionated external-beam radiation therapy,(1-3,6)
in brachytherapy,(5,7,8) and for composite modalities (external beam with brachytherapy).(9)
With modern technologies, multiple radiotherapy treatment modalities are available to treat
cancer. An example of such radiotherapy is prostate cancer being treated with external beam
radiotherapy initially followed by seed implant brachytherapy as a boost treatment. Because
of the dose rate differences between various treatment modalities, the radiation dose cannot be
a
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directly used to compare treatment outcomes of the various modalities. Just as in multimodality treatments, the radiation from hybrid seeds used will be delivered at different dose rates,
since hybrid seeds have a mixture of isotopes. For a lesion treated with different dose rates,
the total dose from the treatments is not meaningful. The biological effective dose (BED), instead of the total dose, from the different modalities or dose rates should be used for treatment
plan evaluation.
In brachytherapy, BED-based optimization would be preferred in planning when multiple dose
rates are involved. Currently, dose-based optimization is common, but BED-based optimization
is not available in commercial treatment planning systems partially due to the complexity in
dose to BED conversion. To make real-time BED-base optimization possible, a fast dose–BED
conversion must be established.
Use of multiple types of seeds and hybrid seeds in brachytherapy have been previously
investigated.(7,10-12) Hybrids seeds, equivalently called multi-isotope seeds, are brachytherapy
sources with more than one isotope. Hybrid seeds are typically denoted with a ratio in front to
indicate the percentage of dose contribution from each isotope to a point in water that is one
centimeter away from the center of the seed. For example, a 50/50 hybrid seed indicates 50%
dose contribution from each isotope, while a 75/25 indicates 75% of the dose comes from the
first isotope and 25% percent of the dose comes from the second isotope (at 1 cm in water). In
this study, we used hybrid seeds that have a mixture of 125I and 103Pd.
Depending on the dose delivery mechanism, calculation of BED from radiation dose is
relatively straightforward. For fractionated external beam radiation therapy, BED follows:(4)
		BED

nd (1

ln 2(T Tk )
d
)
/
Tp

(1)

where, n is the number of fractions, d is the dose per fraction, T is the overall treatment time,
Tp is the cell number doubling time, Tk is time at which repopulation starts after treatment
has started. The terms α and β are radiobiological parameters that categorize radiation effects
on cells.
For brachytherapy using single isotope seeds, the BED equation can be approximated for
clinical applications as:(5)
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Here, D is total dose, d0 is the initial dose rate, μ is the repair coefficient, λ is the isotope
decay constant, and Teff is the effective treatment time.
Due to the mixture of dose rates, the calculation of BED becomes more complicated for
multi-isotope seeds. The mixture of dose rate prevents an analytic expression of Teff and so a
system of equations is needed for calculating BED. The equations necessary for calculating
Journal of Applied Clinical Medical Physics, Vol. 13, No. 5, 2012

26   Pritz et al.: Fast conversion of dose to BED

26

the BED for the multi-isotope seeds are the BED equation(7) and the time derivative of the
BED equation.(8)
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Here N is the number of different types of isotopes; N = 2 for the 2-isotope hybrid seeds.
Numerical computation of BED is possible; however, this process is time consuming.(11)
Without an efficient way of computing BED in hybrid brachytherapy, biological analysis of
treatment plans becomes difficult. Thus, a fast dose–BED conversion method is desirable. The
purpose of this paper is to introduce a fast dose–BED conversion so that BED-based treatment
plan optimization using hybrid brachytherapy seeds is feasible.
In Eq. (2), there is a unique correspondence between total dose and BED for a single isotope
source. Therefore, a dose–BED conversion table can be easily established for single isotope
seeds. However, for hybrid seeds it is possible that a total dose could have multiple corollary
BED values due to the dependence of BED on the initial dose rates, which depend on the distance between the point of interest and the seed. Equation (7) is the formula for total dose, D,
as calculated from the initial dose rate d0i of isotope i. Equation (8) shows the relation of initial
dose rate d0i of isotope i with distance.
			
T1/ 2i
(7)
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j
		
where rj is distance, Si is the air kerma strength, Λi is the dose rate constant, gPi(rj) is the radial dose function and Φan_i(rj) is the anisotropy function. It should be noted that these source
specifications are construction-dependent. The values of the dosimetric parameters are given
in Table 1.
Since each isotope has a different anisotropy and radial dose function, the ratio of dose
contributions from the isotopes will vary with distance. This concept is illustrated in Fig. 1.
Therefore, to generate a dose–BED conversion table for hybrid seeds, the relation of individual
dose contributions to BED, (while maintaining a constant total dose) needs to be established.
Table 1. Values of dosimetric parameters for the hybrid sources.(10) gP(r) and Φan(r) were linearly interpolated.
Strengths, S, as well as the dose rate constant, Λ, are obtained from the manufacturer.(10)
Isotope
125I

103Pd

S (50/50)
(U)

S (75/25)
(U)

S (25/75)
(U)

Λ
(cGy/h/U)

gP(r)
(cm)

Φan(r)
(cm)

λ
(days)

0.22
1.42

0.33
0.71

0.11
2.13

0.95
0.69

1.111 – 0.139r
1.135 – 0.186r

0.212 + 0.075r
0.267 + 0.012r

59.4
17
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Note: Areas in solid curve have relatively constant isotope dose contributions since one seed dominates the contribution
and the isodose line distance to the seed does not vary, therefore the isotope dose contributions do not vary. Areas in
dashed curve have varying distances to a seed thus the isotope dose contributions vary. The arrows are to indicate relative
distances of the seed to points on the isodose line. Points C and D have about the same distances to seed A. Points E and
F have different distances to A.
Fig. 1. Illustration of an isodose line for total dose as a result of two hybrid seeds A and B. Total dose remains the same
along the isodose line; however, individual isotope dose contributions vary.

II. Materials and Methods
Because of the mixture of dose rates, isotope dose contributions along an isodose line will
vary, influencing the BED. To see what variation this causes in BED vs. total dose graphs, the
individual isotope dose components along an isodose line to the corresponding BED values
needs to be examined. A hybrid seed distribution comprising of 49 seeds in a 512 × 512 voxel
plane was generated. From this, the three-dimensional (3D) dose distributions were calculated
in a 512 × 512 × 3 grid with grid size of 0.65 × 0.65 × 3 mm3 for each isotope using Eqs. (7)
and (8). Using the dose distributions from each isotope, the BED distribution can be calculated
using Eqs. (5) and (6). Prostate radiobiological parameters were assigned to each voxel. A graph
of isotope dose contributions vs. BED can be made and analyzed to see how BED is influenced
by the isotope dose contributions.
In the same region, varying the number of sources generates isodose lines along which
isotope dose contributions vary. (A 50 Gy isodose line from a 2 seed distribution will have
different dose contributions from each isotope as compared to a 50 Gy isodose lines from a
49 seed distribution.) This investigation examines the influence of the number of sources, as
well as seed distribution on BED vs. the total dose using Eqs. (7) and (8). The 3D dose distributions were calculated for 2, 5, 10, and 49 seeds distributed in the volume. From these dose
distributions, the BED distributions were calculated using Eqs. (5) and (6). Finally, the total
dose values were coupled by voxel with their corresponding BED values, and a graph of dose
component versus BED was constructed.
If the variation in BED values for a certain total dose was found to be large, then a dose–BED
conversion table would not be useful, clinically. However, if the variation in BED is found to be
small with respect to a total dose value, then practical applications of a dose–BED conversion
table can be considered. A numerical approach was established to calculate BED distributions
from initial dose rate distributions for hybrid seed implant brachytherapy. All numerical calculations were performed and coded for in-house using Mathematica 7.0 software.
Next, a seed distribution and organ contours were taken from a postimplant CT image set in
accordance with the TG-43 protocol.(13) The CT image set was a 512 × 512 × 24 voxel volume
with voxel size 0.65 × 0.65 × 3 mm3. This image set came from a patient previously treated
with single isotope 125I permanent seed implant brachytherapy. This plan was generated and
contoured using the VariSeed program (Varian Medical Systems, Palo Alto, CA). The sources
Journal of Applied Clinical Medical Physics, Vol. 13, No. 5, 2012
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used in this plan were replaced with hybrid seeds. The seed strength was adjusted so that 110 Gy
of BED, which corresponds to 145 Gy of dose for 125I seeds, covered 90% of the prostate.(14)
A dose distribution was then calculated for this hybrid seed set. The BED distribution was calculated based on the dose distribution with the tissue types determined by the contours. Both
the numerical method and the fast conversion method were applied to this case for the dose to
BED conversion and compared. When the numerical approach was used, the component dose
distributions were also used in the conversion, while the fast conversion only used the total
dose distribution.
In addition to calculating dose–BED graphs for a 50/50 hybrid seed, other ratios were investigated, as well. Graphs were also generated for a 75/25 and 25/75 hybrid seed. Strengths of the
seeds were adjusted to reflect the isotope ratios investigated. These strength values are given in
Table 1. Note that Λi, gP i(r) and Φan_i (r) remained the same for these ratios. Once the strengths
were adjusted, dose distributions followed by BED distributions could be calculated.
Because BED can vary depending on the tissue medium, dose vs. BED figures were generated
for multiple tissue types: prostate, bladder wall, rectum, and other normal tissue. Values for the
α, β, and μ used in this study are given in Table 2. For each new set of biological parameters,
the numerical method had to be applied to get the dose–BED correspondence data.
For each total dose vs. BED graph, a line of best fit was determined using Excel’s polynomial fit. Since these equations are analytic, fast calculations can be performed with them. In
optimizing plans using hybrid seeds, these derived equations should be used.
Table 2. Biological parameters used in dose–BED conversion for the various hybrid sources.(9,14,18-23)
Tissue

α (Gy-1)

β (Gy-2)

μ (days)

Tp (days)

Prostate Cancer
Rectum
Bladder
Other Normal Tissue

.15
0.048
0.077
0.2

0.048
0.012
0.02
0.067

0.013
0.016
0.031
0.049

40
60
60
60

III.	Results
Because a hybrid source contains multiple isotopes, the dependency of individual isotope
dose contributions to BED needs to be investigated. The BED, total dose, and individual dose
components were calculated for a 49 seed distribution within a prostate medium for the 50/50
hybrid seed. The individual dose contributions for a given total dose leads to a BED variation
seen in Fig. 2.
Figure 2 shows that for a specific total dose value, multiple individual dose contribution
combinations from each isotope exist. This causes a variation in the BED value for a specific
total dose. However, the variation in BED as compared to the variation in isotope dose contributions is smaller.
Next, an investigation as to whether the number of seeds influences the BED value was
investigated. Figure 3 shows the total dose to BED conversions for a larger range of values for
the 50/50 hybrid seed. The data points for 2, 5, 10, and 49 seeds are seen to overlap, suggesting
that number of seeds does not influence the relation of total dose to BED.
Similar BED uncertainty due to individual dose contribution variations was found for 75/25
and 25/75 hybrid seeds. Since the BED variation was seen to be small, generating total dose
vs. BED graphs can be done. Figure 4 shows the total dose vs. BED graphs for rectal tissue for
hybrid seed ratios of: 50/50, 75/25, and 25/75. From these graphs, polynomial equations can
be fitted. These equations allow for a quick conversion of total dose to BED. For other tissues
(prostate, bladder, and other normal tissue), the numerical technique was applied in order to
Journal of Applied Clinical Medical Physics, Vol. 13, No. 5, 2012
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Fig. 2. The individual isotope contributions to the total dose as well as BED to the total dose relation for 49 seeds is shown.
This graph was calculated for the 50/50 hybrid seeds using the radiobiological parameters for prostate.

Fig. 3. BED vs. the total dose for differing number of seeds and distributions is shown. This graph was calculated for
prostate. “Poly” refers to the polynomial equation fitted to the indicated data.

Fig. 4. BED vs. the total dose calculated for the rectum for hybrid seeds of ratios 25/75, 50/50, and 75/25 are shown.
“Poly” refers to the polynomial equation fitted to the indicated data.
Journal of Applied Clinical Medical Physics, Vol. 13, No. 5, 2012
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obtain the total dose vs. BED dataset. A polynomial equation was generated to fit each dataset.
For these tissues types, the three isotope ratios were investigated.
A polynomial equation to the fourth power was generated by Excel for the following scenarios: rectal, prostate, bladder, and other normal tissues for hybrid seeds of ratio: 50/50, 25/75,
and 75/25. Coefficients for these equations, as well as the maximum differences between the
BED values calculated using the fitted equations and the ones from direct conversion, are listed
in Table 3. The R2 values for all the fits are > 0.999. The general form of the polynomial fit is
given in Eq. (9).
		
BED ( D ) AD 4 BD 3 CD 2 ED F
(9)
Figure 5 shows a comparison of the BED–volume histogram (BEDVH) based on the treatment plan with 125I seeds replaced by the 50/50 hybrid seeds. The comparison is between the
BED values converted from dose using numerical approach and the ones calculated with the
fitted equations. The curves by the equations closely match the ones converted directly by the
Table 3. Coefficients of the fits for the various conversion curves and the maximum differences between the fitted
curves and the direct conversions.
Hybrid Seed
Type

Organ

A

B

50/50
50/50
50/50
50/50
75/25
75/25
75/25
75/25
25/75
25/75
25/75
25/75

Prostate
Rectum
Bladder
NT
Prostate
Rectum
Bladder
NT
Prostate
Rectum
Bladder
NTa

1.074×10-8
1.670×10-8
3.960×10-7
9.729×10-9
2.000×10-8
2.000×10-8
1.917×10-8
1.171×10-8
9.056×10-9
2.222×10-8
1.418×10-8
7.586×10-9

-8.877×10-6
-1.372×10-5
-1.216×10-4
-8.023×10-6
-1.000×10-5
-2.000×10-5
-1.643×10-5
-9.750×10-6
-7.186×10-6
-1.713×10-5
-1.714×10-5
-6.170×10-6

aNT

Coefficients
C
2.802×10-3
4.489×10-3
1.520×10-2
2.968×10-3
0.004
0.006
5.360×10-3
3.325×10-3
2.232×10-3
5.017×10-3
3.868×10-3
2.567×10-3

E

F

Max Error
(Gy)

0.605
0.246
-0.038
0.661
0.465
0.015
0.205
0.594
0.708
0.321
0.494
0.744

-4.765
-7.792
-2.192
-4.923
-4.160
-1.979
-3.784
-5.261
-4.388
-4.402
-5.209
-4.682

1.03
1.75
1.65
1.53
0.85
1.02
1.26
1.13
0.96
1.08
1.32
1.50

= normal tissue

Note: In the legends, “numerical” means the conversion was done by using the numerical method and “equation” means
by fitted equations, or the fast conversion method.
Fig. 5. Comparison of BED–volume histograms between the BED values converted directly from the numerical approach
and the ones calculated using the fitted equations for a clinical treatment plan with the 125I seeds replaced by the 50/50
hybrid seeds and seed strength adjusted.
Journal of Applied Clinical Medical Physics, Vol. 13, No. 5, 2012
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numerical approach. While the numerical approach took over 4 hours to convert the total dose
to BED, the fast conversion method did the conversion for the whole volume of various tissue
types for this plan in about 1 second on a 2.66 GHz PC.
IV. DISCUSSION
The reason for obtaining data from a 2, 5, 10, and 49 seed distributions was to analyze local
seed influence compared to an overall distribution. Seed placement in brachytherapy plans may
sometimes involve placing seeds that are relatively far from other seeds. Therefore, it needs to
be determined if local seed influence differs from the overall distribution when generating the
total dose vs. BED graphs. If it was seen that the total dose vs. BED graph for a 2 seed distribution (local influence) was different then a total dose vs. BED graph from a 49 seed distribution,
then these generated graphs would not be useful.
For specific total dose values, a variation in BED values was seen. This is due to BED being
a function of individual isotope dose contributions and not only the total dose. Since a number
of possible combinations exist to give rise to a specific total dose, this was to be expected.
However, the variation in BED was considered small. (The maximum variation in BED value
was seen to be ~ 2 Gy. When BED is 100 Gy, it is an error of 2%.) An explanation for this is that
not all possible combinations of isotope dose contributions that add up to a specific total dose
exist in the total isodose lines due to the limit of their radial dose and anisotropy functions.
This fast conversion of total dose to BED for low total dose values is not as accurate as
it is for high dose values. The variation in BED values for total dose values around 30 Gy is
roughly the same as in higher total dose values (~ 2 Gy). This results in a relative uncertainty
of ~ 7%. Therefore, the relative uncertainty for low BED values when compared to large BED
is greater (even though the absolute variation was seen to be the same).
The comparison of the BED–volume histograms between the directly converted BED values
by the numerical method and the ones by the fitted equations for a treatment plan shows the
difference is minimal, as shown in Fig. 5. This indicates that this fast conversion method can
be applied clinically with acceptable tolerance. The simplicity of the fast conversion method
is reflected by the conversion time difference between the two methods. The short-time conversion is the major advantage of this method, which makes the BED-based plan optimization
possible in brachytherapy planning.
The update for TG-43(13) recommends a 5th order polynomial be used as the equation of fit
for the anisotropy and radial dose functions. Due to calculation time, a first order approximation was used for the anisotropy and radial dose functions. The applicable range for the radial
dose and anisotropy functions listed is 8 cm. For a more accurate dose distribution beyond this
feasibility study, other types of functions should be used for the fittings.(15,16)
This method can also be confidently applied to single isotope seeds, in which the dose to
BED conversion would be a one-to-one correspondence (the 2 Gy uncertainty of BED would
not exist), which makes the conversion more accurate.
TG-137 states nominal values for α/β ratios when performing BED calculations for the
prostate.(17) Within this study, an α/β ratio of 3.1 was used (TG-137 states to use an α/β ratio
of 3.0). A value of 40 days was assigned to Tp (TG-137 states to use a Tp of 42 days). It was
found that difference in using the TG-137 values amounted to a .3% decrease in calculating the
BED. If a set of biological parameters of great differences is used, a new dose–BED conversion
curve needs to be calculated.
When using the fitted equation to convert dose to BED, for very low doses, the BED values
may be negative, which has no physical meaning. Whenever BED < 0, it should be taken as
BED = 0.
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V.	Conclusions
The work presented in this paper provides a fast calculation method of converting total dose
to BED for 50/50, 75/25, and 25/75 isotope ratios within hybrid seeds. These conversions are
calculated for specific organs: prostate, bladder, rectum, and other normal tissue. In providing a
fast calculation method, the need for solving a series of transcendental equations was bypassed.
This allows for BED-based optimization of treatment plans using these novel brachytherapy
sources. This method can also be applied to other single isotope sources with confidence.
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